M. Foreman

发表

Dopamine deficiency in the weaver mutant mouse

B. Ghetti, K. Perry, M. Schmidt, 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Section Review: Central & Peripheral Nervous Systems: Disorders of sexual response: Pioneering new pharmaceutical and therapeutic opportunities

M. Foreman, 1995 .

Preclinical studies on LY237733, a potent and selective serotonergic antagonist.

R. Fuller, D. Nelson, D. Calligaro, 1992, The Journal of pharmacology and experimental therapeutics.

Effects of Catechol Estrogens1 and Catecholamines on Hypothalamic and Corpus Striatal Tyrosine Hydroxylase Activity

J. C. Porter, M. Foreman, 1980, Journal of neurochemistry.

Cytophotometric analysis of hypothalamic RNA fluctuations during the rat estrous cycle

M. Foreman, A. Anthony, E. W. Wickersham, 1977, Brain Research.

Role of hypothalamic dopaminergic receptors in the control of lordosis behavior in the female rat

R. L. Moss, M. Foreman, 1979, Physiology & Behavior.

Effect of beta-alkyl substitution on D-1 dopamine agonist activity: absolute configuration of beta-methyldopamine.

S. Byrn, R. M. Riggs, L. Truex, 1987, Journal of medicinal chemistry.

Neotrofin increases heme oxygenase-1 selectively in neurons

L. Khawli, M. Maines, Eve M. Taylor, 2003, Brain Research.

Aporphines as antagonists of dopamine D-1 receptors.

N. Mason, J. Schaus, L. Truex, 1990, Journal of medicinal chemistry.

Effects of subcutaneous injection and intrahypothalamic infusion of releasing hormones upon lordotic response to repetitive coital stimulation

R. L. Moss, M. Foreman, 1977, Hormones and Behavior.

Effects of D2-dopaminergic receptor stimulation on male rat sexual behavior

J. Hall, M. Foreman, 2005, Journal of Neural Transmission.

Some aspects of hypothalamic and hypophysial secretion in aging rats

J. C. Porter, N. S. Pilotte, G. Gudelsky, 1980, Peptides.

3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists.

J. Howbert, P. Hipskind, S. Iyengar, 1996, Journal of medicinal chemistry.

Effects of fenfluramine and para-chloroamphetamine on sexual behavior of male rats

James Hall, M. Foreman, R. L. Love, 2005, Psychopharmacology.

Pharmacological characterization of enantiomers of 8‐thiomethyl‐2‐(di‐n‐propylamino)tetralin, potent and selective 5‐HT1A receptor agonists

J. Barrett, D. Wong, R. Fuller, 1995 .

The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.

J. Hall, M. Foreman, R. L. Love, 1989, Life sciences.

Evaluation of isomeric 4-(chlorohydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines as dopamine D-1 antagonists.

R. M. Riggs, L. Truex, D. Nichols, 1987, Journal of medicinal chemistry.

Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogue.

R. M. Riggs, D. Glock, J. Kohli, 1987, Journal of medicinal chemistry.

Effects of D2-dopaminergic receptor stimulation on the lordotic response of female rats

J. Hall, M. Foreman, 2004, Psychopharmacology.

Roles of gonadotropins and releasing hormones in hypothalamic control of lordotic behavior in ovariectomized, estrogen-primed rats.

R. L. Moss, M. Foreman, 1979, Journal of comparative and physiological psychology.

Neuroendocrine control of gonadotropin secretion.

J. Madden, J. C. Porter, G A Gudelsky, 1980, Federation proceedings.

Prolactin augmentation of dopamine and norepinephrine release from superfused medial basal hypothalamic fragments.

J. C. Porter, M. Foreman, 1981, Endocrinology.

Subcellular localization of luteinizing hormone releasing hormone degrading activity in the hypothalamus

J. C. Porter, C. Parker, M. Foreman, 1979, Brain Research.

Role of hypothalamic alpha and beta adrenergic receptors in the control of lordotic behavior in the ovariectomized-estrogen primed rat

R. L. Moss, M. Foreman, 1978, Pharmacology Biochemistry and Behavior.

Role of hypothalamic serotonergic receptors in the control of lordosis behavior in the female rat

R. L. Moss, M. Foreman, 1978, Hormones and Behavior.

In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity

K. Wilcox, J. Stables, M. Eller, 2008, Pharmacology Biochemistry and Behavior.

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α 1-adrenergic receptors in vitro

F. Bymaster, D. Nelson, N. Delapp, 1999, Schizophrenia Research.

Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline.

D. Wong, J. Clemens, R. Fuller, 1983, Journal of medicinal chemistry.

Potentiation of lordosis behavior by intrahypothalamic infusion of synthetic luteinizing hormone-releasing hormone.

R. L. Moss, M. Foreman, 1976, Neuroendocrinology.

RESOLUTION AND ABSOLUTE CONFIGURATION OF AN ERGOLINE-RELATED DOPAMINE AGONIST, TRANS-4,4A,5,6,7,8,8A,9-OCTAHYDRO-5-PROPYL-1H(OR 2H)-PYRAZOLO(3,4-G)QUINOLINE

D. Wong, J. Clemens, R. Fuller, 1983 .

Alterations in K(+)-evoked release of 3H-norepinephrine and contractile responses in urethral and bladder tissues induced by norepinephrine reuptake inhibition.

M. Foreman, A. McNulty, 1993, Life sciences.

Pharmacological characterization of harmaline-induced tremor activity in mice.

B. Olivier, N. Paterson, T. Hanania, 2009, European journal of pharmacology.

Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test.

M. Eller, T. Hanania, M. Foreman, 2009, European journal of pharmacology.

Preclinical studies on LY228729: a potent and selective serotonin1A agonist.

D. Wong, R. Fuller, D. Nelson, 1993, The Journal of pharmacology and experimental therapeutics.

Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.

R. Fuller, D. Nelson, K. Rasmussen, 1994, The Journal of pharmacology and experimental therapeutics.